BNC Korea Co., Ltd. (256840.KQ)
KRW 4160.0
(-1.42%)
KRW 4160.0
(-1.42%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 25.19 Billion KRW | 1.93% |
| 2022 | 25.44 Billion KRW | 13.24% |
| 2021 | 22.46 Billion KRW | 157.4% |
| 2020 | 8.72 Billion KRW | 16.27% |
| 2019 | 7.5 Billion KRW | 48.98% |
| 2018 | 5.03 Billion KRW | 11832.03% |
| 2017 | 42.23 Million KRW | 151.77% |
| 2016 | 16.77 Million KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.6 Billion KRW | 26.1% |
| 2024 Q1 | 5.45 Billion KRW | -17.55% |
| 2023 FY | 25.93 Billion KRW | 1.93% |
| 2023 Q3 | 5.13 Billion KRW | -19.82% |
| 2023 Q4 | 6.61 Billion KRW | 28.82% |
| 2023 Q1 | 7.77 Billion KRW | -11.81% |
| 2023 Q2 | 6.4 Billion KRW | -17.61% |
| 2022 Q2 | 6.12 Billion KRW | 23.58% |
| 2022 FY | 25.44 Billion KRW | 13.24% |
| 2022 Q4 | 8.81 Billion KRW | 55.35% |
| 2022 Q3 | 5.67 Billion KRW | -7.27% |
| 2022 Q1 | 4.95 Billion KRW | -11.58% |
| 2021 FY | 22.46 Billion KRW | 157.4% |
| 2021 Q3 | 4.63 Billion KRW | 0.0% |
| 2021 Q4 | 5.6 Billion KRW | 20.77% |
| 2020 FY | 8.72 Billion KRW | 16.27% |
| 2019 FY | 7.5 Billion KRW | 48.98% |
| 2018 FY | 5.03 Billion KRW | 11832.03% |
| 2017 FY | 42.23 Million KRW | 151.77% |
| 2016 FY | 16.77 Million KRW | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 102.52 Billion KRW | 75.422% |
| CMG Pharmaceutical Co., Ltd. | 37.86 Billion KRW | 33.453% |
| Celltrion Pharm, Inc. | 80.93 Billion KRW | 68.866% |
| Huons Global Co., Ltd. | 294.87 Billion KRW | 91.454% |
| DongKook Pharmaceutical Co., Ltd. | 338.16 Billion KRW | 92.548% |
| Enzychem Lifesciences Corporation | 18.7 Billion KRW | -34.723% |
| Humedix Co., Ltd. | 33.04 Billion KRW | 23.74% |
| Boditech Med Inc. | 47.05 Billion KRW | 46.444% |
| EuBiologics Co., Ltd. | 24.95 Billion KRW | -0.958% |
| FutureChem Co.,Ltd | 9.16 Billion KRW | -174.913% |
| Huons Co., Ltd. | 226.14 Billion KRW | 88.857% |
| AptaBio Therapeutics Inc. | 16.45 Billion KRW | -53.166% |